Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Country/Region as subject
Language
Affiliation country
Publication year range
1.
Scand J Med Sci Sports ; 28(1): 348-355, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28605065

ABSTRACT

Engaging in competitive sports as a youth can have many health benefits, but recent studies also report a high risk for injury. The long-term purpose of this Swedish research program is to develop a framework for safe track and field training for young athletes (aged 12-15 years). The aim of this study was to establish what is perceived to contribute and cause injuries in youth track and field by compiling the best available experiential knowledge about the underlying factors and use this knowledge to identify appropriate areas to handle these in practical ways. Nine focus group interviews with in total 74 participants and confirming interviews with five individuals were performed in seven Swedish regions. Qualitative research methods were used for data analysis. Injuries in youth athletes were not considered to be strictly the result of individual factors but rather the result of the interactions between factors at different levels. Three major factors emerged as follows: Insufficient knowledge for athletic development in daily practice; shortsighted communities of practice and sports policies not adjusted to youth; and societal health behaviors. The experiential knowledge in the national sporting community suggests that if effective and sustainable injury prevention processes are to be implemented for youth track and field, an ecological (holistic-developmental) approach to injury prevention is needed. Such an approach allows a longitudinal development-focused strategy for prevention that spans an athlete's entire career.


Subject(s)
Athletic Injuries/etiology , Athletic Injuries/prevention & control , Track and Field/injuries , Youth Sports/injuries , Adolescent , Adult , Aged , Causality , Female , Focus Groups , Humans , Male , Middle Aged , Qualitative Research , Risk Factors , Sweden , Young Adult
2.
J Nutr Health Aging ; 19(9): 870-7, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26482687

ABSTRACT

BACKGROUND: The impact of supplementation with selenium and coenzyme Q10 (CoQ10) on health-care usage and health-related quality of life (Hr-QoL) in community-dwelling elderly people has, to our knowledge, not previously been investigated. AIM: To investigate the effect of 48 months supplementation with CoQ10 and selenium on community-dwelling elderly as regards: (I) the number of days out of hospital, and (II) the effect on Hr-QoL. METHODS: A 48-month double-blind randomized placebo-controlled trial was carried out. A total of 443 participants were given CoQ10 and organic selenium yeast combined, or a placebo. All admissions to the Department of Internal Medicine or Cardiology were evaluated. Hr-QoL were measured with the Short Form-36 (SF-36), the Cardiac Health Profile (CHP) and one item overall-quality of life (overall-QoL). RESULTS: A total of 206 participants were evaluated after 48 months. No changes were found in the number of days out of hospital or Hr-QoL. A sub-analysis of participants matched for age, gender and baseline cardiac wall tension as measured by NT-proBNP was performed. The mean number of days out of hospital was 1779 for those taking the active substance compared to 1533 for those taking the placebo (p=0.03). Those with active substance declined significantly less in the HR-QoL domains of physical role performance (p=0.001), vitality (p=0.001), physical component score (p=0.001), overall QoL (p=0.001), somatic dimension (p=0.001), conative dimension (p=0.001) and global function (p=0.001). CONCLUSION: In a match-group analysis selenium and CoQ10 increased the number of days out of hospital and slowed the deterioration in Hr-QoL.


Subject(s)
Activities of Daily Living , Dietary Supplements , Hospitalization , Physical Fitness , Quality of Life , Selenium/therapeutic use , Ubiquinone/analogs & derivatives , Aged , Aged, 80 and over , Antioxidants/pharmacology , Antioxidants/therapeutic use , Double-Blind Method , Female , Health Status , Humans , Male , Micronutrients/administration & dosage , Micronutrients/pharmacology , Micronutrients/therapeutic use , Myocardium/metabolism , Natriuretic Peptide, Brain/metabolism , Peptide Fragments/metabolism , Prospective Studies , Selenium/pharmacology , Ubiquinone/pharmacology , Ubiquinone/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL